sec filing
DM
NASDAQ · DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares
Financial Services · Shell Companies
$10.80
Up+$0.00 (+0.00%)
Updated Sep 11, 2026, 12:40 AM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 347.24M
- P/E ratio
- 41.6
- Dividend yield
- 0.00%
- 52-week range
- $10.22 – $10.80
- Volume
- 3.24K
- Avg. volume
- 35.26K
Price performance
DMAA price history
1M range · 0 trading sessions · Daily adjusted prices
DMAA does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest DMAA news
The latest Smart Investors Daily articles mentioning DMAA.
Stock researchCompany · Overview
DMAA research
Overview
Company profile and research snapshot.
Company profile
Drugs Made In America Acquisition Corp is a blank check company.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.